trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Marengo E et al. Evaluation of the variables characterized by significant discriminating power in the application of SIMCA classification method to proteomic studies. 2008 J. Proteome Res. pmid:18543959
Lecona E et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. 2008 Mol. Cell. Biol. pmid:18541673
Gavin DP et al. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. 2008 Schizophr. Res. pmid:18539439
Jiang X et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. 2008 Cancer Cell pmid:18538736
Hoffmann K et al. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? 2008 Epilepsy Res. pmid:18538545
Makki MS et al. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. 2008 Nucleic Acids Res. pmid:18535006
Chung KS et al. Fission yeast-based screening to identify putative HDAC inhibitors using a telomeric reporter strain. 2008 Mol. Cells pmid:18525239
Hou J et al. Epigenetic modification of histone 3 at lysine 9 in sheep zygotes and its relationship with DNA methylation. 2008 BMC Dev. Biol. pmid:18507869
Pan J et al. TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells. 2008 Mol. Cancer Res. pmid:18505930
Cao W et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. 2008 J. Exp. Med. pmid:18504304
Ma P and Schultz RM Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. 2008 Dev. Biol. pmid:18501342
Sun C and Zhou J Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. 2008 Biochem. Pharmacol. pmid:18495085
Chen Y et al. A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. 2008 J. Med. Chem. pmid:18494463
Chu F et al. Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. 2008 Aging Cell pmid:18489729
Egler V et al. Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death. 2008 Clin. Cancer Res. pmid:18483381
Dalgard CL et al. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. 2008 Clin. Cancer Res. pmid:18483379
Hishikawa K and Fujita T [Kidney regeneration update]. 2008 Nippon Rinsho pmid:18464514
Mackay CL et al. Sensitive, specific, and quantitative FTICR mass spectrometry of combinatorial post-translational modifications in intact histone H4. 2008 Anal. Chem. pmid:18457408
Moynihan AT et al. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. 2008 Am. J. Obstet. Gynecol. pmid:18455134
Geli J et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. 2008 Int. J. Cancer pmid:18452173
van West P et al. Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. 2008 Microbiology (Reading, Engl.) pmid:18451057
Jensen TJ et al. Epigenetic remodeling during arsenical-induced malignant transformation. 2008 Carcinogenesis pmid:18448484
Yu C et al. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. 2008 Neuro-oncology pmid:18445700
Xu LN et al. Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines. 2008 World J. Gastroenterol. pmid:18442209
Zhang HJ et al. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. 2008 Placenta pmid:18440631
Kikuno N et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. 2008 Int. J. Cancer pmid:18431742
Mazitschek R et al. Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. 2008 Bioorg. Med. Chem. Lett. pmid:18430569
Sebastián C et al. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. 2008 J. Immunol. pmid:18424709
Meja KK et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. 2008 Am. J. Respir. Cell Mol. Biol. pmid:18421014
Habold C et al. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. 2008 J. Cell. Mol. Med. pmid:18419600
Iager AE et al. Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos. 2008 Cloning Stem Cells pmid:18419249
Jeseta M et al. In vitro ageing of pig oocytes: effects of the histone deacetylase inhibitor trichostatin A. 2008 Zygote pmid:18405435
Kaipparettu BA et al. Estrogen-mediated downregulation of CD24 in breast cancer cells. 2008 Int. J. Cancer pmid:18404683
Kawamoto K et al. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. 2008 Int. J. Cancer pmid:18404682
Roy S et al. Histone deacetylase 5 represses the transcription of cyclin D3. 2008 J. Cell. Biochem. pmid:18404677
Ko JM et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. 2008 Mol. Cancer Res. pmid:18403638
Yan C et al. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors. 2008 Proteins pmid:18398905
Chen PC et al. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. 2008 Bioorg. Med. Chem. pmid:18397827
Nakao Y et al. Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. 2008 Bioorg. Med. Chem. Lett. pmid:18397826
Qi J et al. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor]. 2007 Zhonghua Zhong Liu Za Zhi pmid:18396643
Galiová G et al. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. 2008 Eur. J. Cell Biol. pmid:18396346
Karantzali E et al. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. 2008 Genome Biol. pmid:18394158
Liu TC et al. Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. 2008 Mol. Ther. pmid:18388912
Rebbaa A et al. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. 2008 Angiogenesis pmid:18386142
Pandey SC et al. Brain chromatin remodeling: a novel mechanism of alcoholism. 2008 J. Neurosci. pmid:18385331
Lin YC et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. 2008 Cancer Res. pmid:18381445
Xu ZM et al. The novel gene LRP15 is regulated by DNA methylation and confers increased efficiency of DNA repair of ultraviolet-induced DNA damage. 2008 BMB Rep pmid:18377727
Lindström TM et al. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells. 2008 Mol. Pharmacol. pmid:18375836
Biacsi R et al. SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. 2008 PLoS Genet. pmid:18369442
Vrbova G Spinal muscular atrophy: motoneurone or muscle disease? 2008 Neuromuscul. Disord. pmid:18365338
Brown SL et al. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. 2008 Radiat. Res. pmid:18363436
Mukherjee P et al. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. 2008 Bioorg. Med. Chem. pmid:18362073
Svechnikova I et al. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. 2008 Int. J. Oncol. pmid:18360709
Wei Q et al. [Effect of trichostatin A on proliferation and interleukin-2 expression of mouse T cells in mixed lymphocyte culture]. 2008 Nan Fang Yi Ke Da Xue Xue Bao pmid:18359716
Henkens T et al. Differential effects of hydroxamate histone deacetylase inhibitors on cellular functionality and gap junctions in primary cultures of mitogen-stimulated hepatocytes. 2008 Toxicol. Lett. pmid:18358644
Kimata Y et al. Diminishing HDACs by drugs or mutations promotes normal or abnormal sister chromatid separation by affecting APC/C and adherin. 2008 J. Cell. Sci. pmid:18354085
Balakrishnan L and Milavetz B HDAC inhibitors stimulate viral transcription by multiple mechanisms. 2008 Virol. J. pmid:18353181
Borghol N et al. Transcriptional and epigenetic status of protamine 1 and 2 genes following round spermatids injection into mouse oocytes. 2008 Genomics pmid:18343090
Countryman JK et al. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. 2008 J. Virol. pmid:18337569
Fantini D et al. APE1/Ref-1 regulates PTEN expression mediated by Egr-1. 2008 Free Radic. Res. pmid:18324520
Fleury L et al. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells. 2008 Oncogene pmid:18317449
Brown CR et al. Global histone acetylation induces functional genomic reorganization at mammalian nuclear pore complexes. 2008 Genes Dev. pmid:18316479
Kim M et al. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. 2008 Mol. Cancer Res. pmid:18314483
Dong G et al. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. 2008 J. Pharmacol. Exp. Ther. pmid:18310471
Jiang Y et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. 2008 J. Exp. Biol. pmid:18310117
Suuronen T et al. Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. 2008 Neurochem. Res. pmid:18307035
Lin W et al. Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40. 2008 Genes Cells pmid:18298800
Horswill MA et al. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. 2008 Exp. Eye Res. pmid:18291368
Schuetz A et al. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. 2008 J. Biol. Chem. pmid:18285338
Nakamura C et al. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells. 2008 Rheumatology (Oxford) pmid:18281366
Oliva J et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. 2008 Exp. Mol. Pathol. pmid:18280469
Kovács P et al. Effect of histone deacetylase inhibitor trichostatin A (TSA) on the microtubular system of Tetrahymena. 2007 Acta. Biol. Hung. pmid:18277464
Kang JH et al. CCAAT box is required for the induction of human thrombospondin-1 gene by trichostatin A. 2008 J. Cell. Biochem. pmid:18275041
Sasaki K et al. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. 2008 Cancer Sci. pmid:18271940
Shi LH et al. Trichostatin A (TSA) improves the development of rabbit-rabbit intraspecies cloned embryos, but not rabbit-human interspecies cloned embryos. 2008 Dev. Dyn. pmid:18265023
Fan J et al. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. 2008 J. Cancer Res. Clin. Oncol. pmid:18264725
Politis PK et al. BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells. 2008 FEBS Lett. pmid:18258204
Mazzarelli P et al. Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? 2007 Cancer Biol. Ther. pmid:18253084
Gupta MP et al. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. 2008 J. Biol. Chem. pmid:18250163
Paris M et al. Histone deacetylase inhibitors: from bench to clinic. 2008 J. Med. Chem. pmid:18247554
Shi LH et al. Trichostatin A and nuclear reprogramming of cloned rabbit embryos. 2008 J. Anim. Sci. pmid:18245503
Li X et al. The effects of trichostatin A on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts. 2008 Cloning Stem Cells pmid:18241125
Wang Q et al. The spatial relationship between heterochromatin protein 1 alpha and histone modifications during mouse oocyte meiosis. 2008 Cell Cycle pmid:18239470
Tang Y et al. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. 2008 Circ. Res. pmid:18239137
Yildirim F et al. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. 2008 Exp. Neurol. pmid:18234195
Lim HG et al. Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro. 2008 Mol. Ther. pmid:18227841
Nasu Y et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. 2008 Osteoarthr. Cartil. pmid:18226559
Kuwajima A et al. The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. 2007 Nov-Dec Anticancer Res. pmid:18225587
Yasuda K et al. ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. 2007 Nov-Dec Anticancer Res. pmid:18225573
Jiemjit A et al. p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage. 2008 Oncogene pmid:18223691
Andrews KT et al. Potent antimalarial activity of histone deacetylase inhibitor analogues. 2008 Antimicrob. Agents Chemother. pmid:18212103
Yu WP et al. Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells. 2008 Cell Prolif. pmid:18211287
Duhamel M et al. Differential epigenetic regulation of Aiolos expression in human tumoral cell lines and primary cells. 2008 FEBS Lett. pmid:18206652
Hamner JB et al. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma. 2008 J. Pediatr. Surg. pmid:18206478
Serrano E et al. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias. 2008 Leuk. Res. pmid:18206229
Ruau D et al. Pluripotency associated genes are reactivated by chromatin-modifying agents in neurosphere cells. 2008 Stem Cells pmid:18203677
Isakov E et al. Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica. 2008 Mol. Biochem. Parasitol. pmid:18191469
Heller G et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. 2008 Cancer Res. pmid:18172295
Wu ZQ et al. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. 2007 Chin. Med. J. pmid:18167185
Joseph RA et al. Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein trafficking. 2008 Hepatology pmid:18161881